The recent discovery that an additional estrogen receptor subtype is present in various rat tissues has advanced our understanding of the mechanisms underlying estrogen signaling. Here we report on the cloning of the cDNA encoding the mouse homolog of estrogen receptor-␤ (ER␤) and the functional characterization of mouse ER␤ protein. ER␤ is shown to have overlapping DNA-binding specificity with that of the estrogen receptor-␣ (ER␣) and activates transcription of reporter gene constructs containing estrogen-response elements in transient transfections in response to estradiol. Using a mammalian two-hybrid system, the formation of heterodimers of the ER␤ and ER␣ subtypes was demonstrated. Furthermore, ER␤ and ER␣ form heterodimeric complexes with retained DNA-binding ability and specificity in vitro. In addition, DNA binding by the ER␤/ER␣ heterodimer appears to be dependent on both subtype proteins. Taken together these results suggest the existence of two previously unrecognized pathways of estrogen signaling; I, via ER␤ in cells exclusively expressing this subtype, and II, via the formation of heterodimers in cells expressing both receptor subtypes.
INTRODUCTION
Nuclear receptors represent a large family of transcription factors that regulate the activity of target genes by direct binding to specific DNA recognition elements located in the vicinity of the transcription start site of genes. Members of this gene family have an evolutionary and functionally conserved structure with a hypervariable N-terminal region that contributes to the transactivation function, a centrally located, well conserved DNA-binding domain (DBD), and a C-terminal domain involved in ligand binding, dimerization and transactivation functions (1) .
Steroid hormone receptors constitute a distinct subgroup within the nuclear receptor family (2) , which includes receptors for glucocorticoids, mineralocorticoids, androgens, progestins, and estrogens [glucocorticoid receptor, mineralocorticoid receptor, androgen receptor, progesterone receptor, and estrogen receptor (ER), respectively]. In addition two orphan nuclear receptors, the ERR-1 and 2 (ER-related receptors) (3) have been referred to this group (4) . The steroid hormone receptors bind as homodimers to palindromic DNA response elements (2) . Another important feature of steroid hormone receptors is the interaction with the molecular chaperone hsp 90 (5) .
Estrogens influence growth, differentiation, and function of many target tissues, including tissues of the female and male reproductive tract (6) . Estrogens also play an important role in the maintenance of bone mass and in the cardiovascular system where estrogens have certain protective effects (7, 8) . The ERencoding cDNAs have been cloned from several species (9) (10) (11) (12) . Important examples of genes regulated by estrogens are the PR, epidermal growth factor receptor, certain growth factors (insulin-like growth factor-I, transforming growth factor-␣ and -␤) and several protooncogenes (c-fos, c-myc, c-jun) (13) . Loss of ER function has long been postulated to be incompatible with life, and therefore the successful generation of ER-deficient mice came as a surprise (14) . These mice are viable but display severe dysfunction of the reproductive organs, and both sexes are sterile. The females have hypoplastic uteri and hyperemic ovaries with no detectable corpora lutea. The fact that disruption of the ER gene did not completely eliminate the ability of small follicles to grow, as was evident from the presence of secondary and antral follicles in the knock-out mouse ovary, pointed to the possible existence of alternative ER mediating the intraovarian effects of estradiol. In some tissues from the ER knockout mice residual binding of estradiol with an affinity and specificity reminiscent of an ER protein could be measured (14, 15) . We have recently cloned a novel ER cDNA from rat prostate (16) , which was suggested to be named rat ER␤ subtype to distinguish it from the previously cloned ER cDNA (consequently ER␣ subtype). The rat ER␤ protein was found to be highly homologous to the rat ER␣ protein, particularly in the DBD (Ͼ95% amino acid identity) and in the C-terminal ligand-binding domain (55% amino acid identity). In ligand-binding assays rat ER␤ binds estrogens with an affinity and specificity resembling that of ER␣, and ER␤ is able to activate transcription of an estrogenresponse element containing reporter gene construct (16, 17) . In subsequent studies it was shown that ER␤ is the primary ER subtype expressed in rat ovary and that ER␤ message is down-regulated by gonadotropins in granulosa cells, suggesting that the functional significance of estrogen action in the rat ovary may be mediated primarily by ER␤ (18) .
The detailed biological significance of the existence of two ERs is presently unclear. Perhaps the existence of two ER subtypes may provide, at least in part, an explanation for the selective actions of estrogens and certain antiestrogens in different target tissues (19, 20) .
In this paper we describe the cloning of the mouse ovary ER␤-cDNA and the characterization of the mouse ER␤ protein with respect to DNA binding, homo-and heterodimerization, and transactivational functions. Finally, cotransfection of both ER subtypes with an estrogen response element (ERE) containing reporter gene construct showed that the formation of heterodimeric ER␣/ER␤ complexes may indeed constitute a novel estrogenic gene-regulatory pathway.
RESULTS AND DISCUSSION

A Homolog of Rat ER␤ Is Expressed in Mouse Ovary
The recent discovery of a novel ER protein present in rat prostate and ovary (16) has given a new perspective to studies of estrogen action. The mouse represents an important model system for studies of gene function in mammals. We therefore investigated whether a homolog to the previously cloned rat ER␤ (rER␤) is present in the mouse. Oligonucleotides, constructed to encompass the coding sequence of the rER␤ cDNA, were used in an RT-PCR amplification of total RNA isolated from mouse ovaries. Amplification products with the expected size (ϳ1.5 kbp) were subcloned and sequenced. The open reading frame of these clones displayed a high degree of amino acid identity with the rER␤ protein and were therefore recognized as the mouse homolog of rER␤ and will hereafter be referred to as the mouse ER␤ (mER␤). As shown in Fig. 1 , the mER␤ amino acid sequence also manifests considerable similarities to mouse and rat ER␣ in the DNAand ligand-binding domains (Fig. 1) . Several amino acid residues that have been demonstrated to be required for high-affinity binding of estradiol by ER␣ (21) were found to be conserved in rat ER␤. The rat ER␤ binds estradiol (E 2 ) with an affinity very comparable to that of ER␣ (17) . Since the same amino acid residues are also conserved in the ligand-binding domain of mER␤, we concluded that mER␤ should bind E 2 in a similar manner as the rat ER␤.
mER␤ Protein Binds to an ERE
Members of the nuclear receptor superfamily bind to specific DNA motifs, generally palindromic or direct repeats of the sequence AG(A/G)(A/T)CA (22) located in the vicinity of the promoter of target genes. The specificity of DNA recognition by nuclear receptors is mediated essentially through the so called P-box, a short stretch of amino acids located in the N-terminal zinc finger in the DNA binding domain (DBD) (Ref. 1 and references therein). Amino acids in the P-box have been demonstrated to make direct contacts with bases in the DNA response elements, thus participating in dictating the DNA binding specificity (23) . The P-box of ER␣ (EGCKA) differs from the P-box of other members of the steroid receptor subgroup, such as glucocorticoid receptor and progesterone receptor, with the result that ER␣ recognizes DNA elements contrasting from the sequences recognized by GR and PR. The consensus ERE consists of a palindromic repeat of the core sequence AGGTCA spaced by three nucleotides (24) . The high degree of conservation in the DBD of the ␣ and ␤ ER subtypes (ϳ96%, Fig. 1 ) and the absolute identity of the P-box sequences strongly suggest a shared DNA recognition specificity between the two ER subtypes. We consequently performed DNA binding studies with mER␤ using radiolabeled consensus ERE oligonucleotides.
Mouse ER␤ and human ER␣ protein were synthesized in vitro in a rabbit reticulocyte lysate (RRL) system before incubation with E 2 and a radiolabeled double-stranded ERE oligonucleotide. The resulting DNA-protein complexes were analyzed by electrophoretic gel mobility shift assay (Fig. 2) . ER␤ binds to the wild type consensus ERE both in the absence or presence of E 2 (lanes 2 and 3), but not to an ERE mutated in both half-sites (Fig. 2, lanes 7 and 8) . This coincides with the binding specificity of ER␣ (Fig. 2 , lanes 4 and 5 and lanes 9 and 10, respectively). In contrast to results obtained in a recent study by Tremblay and co-workers (25), we did not observe a reduced affinity for the ERE by ER␤ when equal amounts of ER␣ and ER␤ protein were used (as quantitated by [ 35 S]methionine labeling). The reason for this discrepancy is unclear.
ER␤ Binds to the ERE as a Homodimer
Efficient DNA binding and transactivation function of nuclear receptors are often dependent on the forma-tion of dimers. Members of the steroid receptor subgroup have been shown to interact with DNA predominantly as homodimers, whereas the receptors for retinoic acid, thyroid hormone, and vitamin D, as well as several orphan nuclear receptors, form heterodimeric complexes with the ubiquitous partner RXR (retinoid X receptor) (26) . Importantly, some orphan nuclear receptors have been demonstrated to bind to DNA as monomers (27) . To establish whether mER␤ binds to DNA as a homodimer or as a monomer, we generated a deletion mutant construct in which the 91 most N-terminal amino acids of the A/B domain of ER␤ were removed (Fig. 3A) . This region of steroid receptors has not been shown to participate in DNA recognition, and we therefore anticipated that the truncated mER␤ would be able to bind to DNA as efficiently as the wild type receptor. The mER␤ construct was also tagged with a nine-amino acid HA1-epitope, which is recognized by the monoclonal 12CA5 antibody (28) . The truncated epitope-tagged mER␤ (ER␤-TAG) in electrophoretic mobility shift assays gave rise to a DNA-protein complex clearly distinguishable from the complex formed by the wild type ER␤ (ER␤-wt), (Fig.  3B ). After mixed synthesis of ER␤-TAG and ER␤-wt in The DBD is boxed, the two zinc fingers over-lined (CI, CII), and the ligand-binding domain is boxed and shaded.
the RRL system, a third complex of intermediate mobility was visible (Fig. 3B , lanes 2-4) representing the dimer between wtER␤ and ER␤-TAG. This experiment clearly shows that ER␤ binds to DNA as a homodimer, similar to the binding of ER␣ (Refs. 1 and 2 and references therein).
Coexpression of ER␤ and ER␣ Does Not Inhibit ER␣-Stimulated Activity of an ERE-Reporter Gene Construct
Having established the ability of mER␤ to bind to an ERE, we proceeded to characterize the capacity of mER␤ to activate transcription of an ERE-containing reporter gene in transient cotransfections of mammalian cells. We also wanted to study whether cotransfection of both ER subtypes would alter the activity of the ERE reporter construct. Human fetal kidney 293 cells were cotransfected with a luciferase enzyme reporter gene construct containing two copies of a consensus ERE in front of a thymidine kinase promoter, together with human ER␣-or mER␤-expressing plasmids, or both. As shown in Fig. 4 , the E 2 -stimulated activity of the reporter gene construct by mER␤ was lower when compared with the activity obtained with ER␣ when studied under the same transfection conditions. The 2-fold lower E 2 -stimulated activity was not P-labeled DNA fragments corresponding to a consensus ERE (lanes 1-5) or a derivative ERE mutated in both half-sites (lanes 6-10) were incubated with unprogrammed lysate (lanes 1 and 6) or ER␤ (lanes 2-3 and 7-8) or ER␣ (lanes 4-5 and 9-10) synthesized in the RRL system. DNA-protein complexes were fractionated on a nondenaturing acrylamide gel. The gel was dried and autoradiographed at Ϫ70 C.
Fig. 3. ER␤ Binds to the ERE as a Dimer
A, Schematic presentation of the wild type ER␤ (ER␤-wt) and the truncated receptor (ER␤-TAG). The DBD and the LBD are overlined in the wild type receptor. The inserted hemaglutenine (HA) epitope of the ER␤-TAG is indicated (dotted) and overlined. B, 32 P-labeled consensus ERE was incubated with wild type ER␤ alone (ER␤-wt, lane 1), or ER␤-TAG alone (lane 5), or both proteins together in 3:1, 1:1, and 1:3 ratios (lanes 2, 3, and 4, respectively) after synthesis in the RRL system. DNA-protein complexes were analyzed as described in the legend to Fig. 2 . Arrows point to complexes formed by ER␤-wt and ER␤-TAG as indicated. The arrow without label indicates the band with intermediate migration, which represents the heterodimer of wild type and truncated receptors (lanes 2-4). due to squelching of mER␤, since the reporter activity was dose-dependent with regard to the amount of cotransfected mER␤-expression plasmid (data not shown). Although ER␤ and ER␣ are highly homologous in the DBD and in parts of the ligand-binding domain (LBD), there remain substantial differences, particularly in the N-terminal A/B domain (Fig. 1) . This domain contains the AF-1 transcriptional activity function of ER␣ (29) and may have a similar function in ER␤. The diverging A/B domains and/or dissimilarities in the LBD of ER␤ and ER␣ may result in differences in maximal transactivational activity of both ER subtypes. The slightly lower maximal transactivational activity of ER␤ compared with ER␣ has also been observed by other investigators (25, 30) . When ER␣ and ER␤ were cotransfected, however, the reporter activity did not change significantly, when compared with the activity observed with ER␣ alone (Fig. 4) . Based on these observations we conclude that ER␤ does not repress the activity of ER␣. Furthermore, if the two receptors were competing as homodimers for the ERE-binding sites, higher concentrations of ER␤ would be expected to result in a decrease in reporter activity, toward the activity pattern of ER␤ alone. Since no sign of such a competition was observed, we speculated that an interaction was taking place between the two ER subtypes (although we cannot rule out that ER␣ alone is responsible for the transcriptional activity of the reporter gene). To be able to monitor a possible interaction between ER␤ and ER␣, we used a mammalian cell two-hybrid system.
ER␤ Interacts with ER␣ in Vivo and in Vitro
The two-hybrid system provides a powerful technique for studying potential interactions between two proteins within a cell. The principle is, in short, to fuse protein A to an autonomous DBD and protein B to a strong transactivation domain. The hybrid protein constructs are cotransfected into cells together with a reporter gene construct containing the cognate response element. The activity of the reporter gene will depend on an interaction between the fusion proteins, which will direct the transactivation domain to the promoter. The system has been widely used in yeast, but is also applicable in mammalian cells. For our studies we chose to use the DBD of the yeast protein Gal4 and the transactivation domain of the viral factor VP16. The Gal4-DBD was fused to the full-length mER␣, and the VP16 transactivation domain was coupled to full-length mER␣ and mER␤, respectively (Fig.  5A ). The chimera constructs were then cotransfected together with a Gal4-luciferase reporter construct into COS 7 cells. Comparisons were made between cells with or without E 2 incubation. Reporter activity remained low when cells were transfected with the vectors expressing only the Gal4-DBD or the VP16 transactivation domain, or when either of these constructs was transfected together with any of the hybrid constructs (Fig. 5B) . In contrast, when the Gal4-mER␣ construct was transfected together with the VP16-mER␣ construct or the VP16-mER␤ construct, the activity of the reporter was induced approximately 3-to 4-fold, respectively (Fig. 5B , two most right-hand panels, white bars), compared with reporter transfected alone, indicating an interaction between the chimeric proteins. In the presence of E 2 the induction levels rose to about 18-fold (Fig. 5B , two most righthand panels, black bars). These results clearly demonstrate an interaction between the mER␤ and mER␣ proteins in vivo, suggesting that the transcriptional activity observed during coexpression of ER␣ and ER␤ (Fig. 4) is, at least in part, due to the formation of ER␣/ER␤ heterodimers. The rise in reporter activity observed, especially in the presence of E 2 (ϳ5-fold), with the Gal4-mER␣ hybrid and the original VP-16 construct (Fig. 5B, second panel) is in all likelihood due to the ligand-inducible transactivation function of ER␣ itself, when directed to the promoter of the Gal4 reporter gene construct by binding via the Gal4 DBD.
We also performed glutathione S-transferase (GST) pulldown experiments with [
35 S]methionine-labeled ER␣ and a GST-mER␤ fusion protein, in order to detect a direct interaction between the two proteins in vitro. As shown in Fig. 5C , ER␣ could be successfully coprecipitated with the GST-mER␤ fusion protein but not with the GST alone (compare lane 2 to lane 3, lane 1 ϭ input of ER␣, 20%), demonstrating a direct interaction between both ER subtypes. 
ER␤ and ER␣ Form DNA-Binding Heterodimers
The results from the two-hybrid assay and from the pulldown experiment suggested that ER␣ and ER␤ are able to form heterodimers. In combination with the results from the cotransfection experiments (Fig. 4) , it appeared likely that the putative ER␤/ER␣ heterodimer would be able to bind to an ERE.
We performed electrophoretic mobility shift assay with in vitro synthesized ER␣ and ER␤ to examine this possibility. Because the wild type ER␤ migrates closely with ER␣ on native gels (see Fig. 2 ), we decided to use the truncated ER␤-TAG (described above and in Materials and Methods) in order to identify DNA-protein complexes. ER␤-TAG and ER␣ were synthesized in vitro and then mixed at increasing and decreasing amounts, respectively, incubated on ice, followed by incubation with the 32 P-labeled ERE. An ERE-protein complex of intermediate mobility was formed in samples in which the two ER subtypes were coincubated (Fig. 6A, lanes 2-5) , probably representing a heterodimeric complex between ER␤-TAG and ER␣. This putative heterodimerization was also evident when full-length wt ER␤ was used instead of ER␤-TAG, but the complexes were not as easily distinguished (not shown).
To confirm the presence of both ER subtypes in the heterodimeric complex, the DNA-binding assay was also performed in the presence of an ER␣ antibody and the 12CA5 antibody. Figure 6B shows the result of incubation with the monoclonal ER␣ antibody 1D5. The ER␣ homodimer is efficiently supershifted with this antibody as expected (Fig. 6B , lane 3 compared with lane 2), whereas the ER␤ homodimer is not affected (lanes 9 and 10). The intermediate complex formed in the presence of both ER␣ and ER␤-TAG is also supershifted with the ER␣ antibody (Fig. 6B , lanes 5-8 compared with lane 4), thus demonstrating the presence of ER␣ within the heterodimeric complex. In Fig. 6C essentially the same experiment has been repeated using the 12CA5 monoclonal antibody directed against the HA-epitope of mER␤-TAG. The 12CA5 antibody successfully interacts with both the ER␤ homodimer and the intermediate complex previously shown to contain also ER␣ (Fig. 6C, lanes 10 and  4-7) . The 12CA5 antibody does not cross-react with containing Gal4-binding sites and expression plasmids for Gal4 (Gal4-), VP16 (VP16-), Gal4-ER␣, VP16-ER␣, and VP16-ER␤ as indicated. The cells were treated with vehicle (Ϫ, white bars) or 1 M 17␤-estradiol (1 M E 2 , black bars). Data are presented as fold induction and represent the mean Ϯ SD of three separate experiments performed in duplicate. The values obtained from cells transfected with reporter alone and treated with vehicle were arbitrarily set to 1. C, ER␣ was labeled with [ 35 S]methionine by translation in RRL and incubated with GST-mER␤ or GST-protein. Samples were subsequently incubated with GST-Sepharose, washed, eluted in SDS buffer, and separated on 10% SDS-PAGE gels.
Fig. 5. ER␤ Interacts with ER␣ in a Mammalian Two-Hybrid Protein System
A, Schematic description of the fusion proteins used in the two-hybrid assay. The Gal4-DBD was fused to the full-length ER␣, creating Gal4-ER␣, and the transactivating domain of VP16 (VP16-TA) was linked to full-length ER␣ and ER␤, creating VP16-ER␣ and VP16-ER␤, respectively. B, COS-7 cells were transfected with a luciferase reporter plasmid A, ER␣ or ER␤-TAG alone (lanes 1 and 7, respectively) or together as indicated (lanes 2-6) were incubated with a 32 P-labeled consensus ERE, and DNA-protein complexes were separated on a nondenaturing acrylamide gel. The arrow indicates the intermediate complex formed in the presence of both ER␣ and ER␤. B, ER␣ or ER␤-TAG alone or together were incubated with a mouse monoclonal ER␣-specific antibody (ER␣ ab, lanes 3, 5-8, and 10) or with no antibody (lanes 2 and 9) together with 32 P-labeled ERE. Complexes were analyzed as above. C, Essentially the same experiment as in B except that the 12CA5-TAG antibody recognizing the epitope-tagged ER␤ (TAG ab, lanes 2, 4-7 and 9), or no antibody was used (lanes 1, 3, and 8) . D, 32 P-labeled DNA fragments corresponding to either a consensus ERE (lanes 1-4) or a derivative ERE mutated in one of the half-sites (lanes 5-8) were incubated with unprogrammed lysate (lanes 1 and 5) or ER␣ (lanes 2 and 6) or ER␤ (lanes 3 and 7) or a mixture of both ER␣ and ER␤ (lanes 4 and 8) . DNA-protein complexes were analyzed as described above.
the ER␣ homodimer (lane 2)
. These results clearly demonstrate that the intermediate complex that is formed when ER␣ and ER␤ are coincubated contains both receptors and is a true heterodimeric complex.
To determine whether both partners of the heterodimer participate in DNA binding, experiments were performed with an ERE mutated in one of the half-sites at a position previously demonstrated to be crucial for efficient binding by the ER␣ protein (31) . In crystallographic studies of the DBD of ER␣ bound to the ERE (31), it was established that a mutation in one of the half-sites resulted in reduced cooperativity in binding to the second half-site, due to lack of proper interaction between the dimer interfaces present in the DBD. Binding by ER␣ to such a mutated ERE was therefore less efficient. We found that ER␤ did not bind to this mutated ERE in analogy to the ER␣ (Fig. 6D , lanes 7 and 6, respectively). In addition, no protein-DNA complex was formed with the heterodimer (lane 8), indicating that cooperativity in DNA binding is also required for efficient DNA binding by ER␤/ER␣ heterodimers.
Furthermore, the ER␤ as well as ER␣ were unable to bind to oligonucleotides containing direct repeats of the core sequence AGGTCA spaced by one or four nucleotides (DR1 or DR4), irrespective of the presence or absence of retinoid X receptor (data not shown).
Our findings on ER␣/ER␤ heterodimerization and the recent demonstration of GR/MR heterodimerization (32-33) challenge the commonly held view that steroid receptors form only homodimers. Previous biochemical and structural evidence indicated that steroid receptors form homodimers through a dimerization interface within their zinc finger DNA binding domain, and a generally much stronger dimerization interface within the ligand binding domain (Refs. 1 and 22 and references therein). Further studies will be required to localize the dimerization interfaces involved in the formation of ER␣/ER␤ heterodimers.
The rat tissue distribution and/or relative level of ER␣ and ER␤ mRNA seems to be quite different; that is, moderate to high expression in uterus, testis, pituitary, ovary, kidney, epididymis, and adrenal for ER␣ and prostate, ovary, uterus, lung, bladder, brain, and testis for ER␤ (17) . This may imply that in testis and ovary both subtypes are expressed to some extent. In the mouse, both ER mRNAs can be found in ovary and uterus (not shown). In the rat, hypothalamus ER␣ and ER␤ are coexpressed in certain regions, most likely in the same neurons (34) . The coexpression of ER␣ and ER␤ in the same tissue and/or cells suggests the interesting possibility that ER␣ and ER␤ proteins may interact with each other. In this study we have indeed shown that the two ER subtypes have the ability to form heterodimers. The discovery of an ER␤ protein and the ability of ER␣ and ER␤ to form heterodimers strongly suggest the existence of two previously unrecognized pathways of estrogen signaling: via ER␤ homodimers in cells exclusively expressing this subtype and via ER␣/ER␤ heterodimers in cells expressing both subtypes (Fig. 7) . The ER␤ homodimers and the ER␣/ER␤ heterodimers may possibly interact with novel response elements, different from the known EREs. By such a mechanism the physiological regulatory potential of estrogenic hormones may be greatly expanded. Different target tissues may respond differently to the same hormonal stimulus due to alternative composition of receptors. Varying ratios of ER␣ and ER␤ in different cells, resulting in different populations of homo-and heterodimers, could constitute a hitherto unrecognized mechanism involved in the tissue-and cell type-specific effects of estrogens and certain antiestrogens (19, 20) .
Future studies will be required to determine the physiological significance of the existence of more than one ER protein.
Fig. 7. Alternative Estrogen-Signaling Pathways
The existence of two ER subtypes and their ability to form DNA-binding heterodimers suggests the existence of three potential alternative pathways of estrogen signaling. In cells expressing only the ER␣ or ER␤ subtype, homodimers of either subtype can interact with response elements in target gene promoters and influence transcription levels. In cells expressing both subtypes, heterodimers can be formed depending on the ratio of the subtypes. Although we have shown that ER␤ homodimers and ER␣/ER␤-heterodimers interact with consensus EREs, it cannot be excluded at this stage that unique response elements exist within the context of target gene promoters that interact preferentially with the ER␤ homodimer or the ER␣/ER␤-heterodimer. In that way, the regulatory potential of the liganded ER protein could be greatly expanded. An open question in this regard is the existence of estrogen target genes that are exclusively regulated by either of the homodimers or the heterodimer.
MATERIALS AND METHODS
Cloning of Mouse ER␤ cDNA
Total RNA from ovaries dissected from 5-week-old mice was prepared as described (35) . Complementary DNA was synthesized using Super-Script reverse transcriptase (GIBCO BRL, Paisley, Scotland) as described previously (36) using 1 g of total RNA. PCR amplification of the cDNA was carried out with 35 cycles of repeated denaturation for 15 sec at 95 C, 15 sec of annealing at 57 C, and 60 sec of extension at 72 C with Taq-polymerase (Pharmacia, Uppsala, Sweden) under the conditions described by the manufacturer with 1:20 of synthesized cDNA and oligonucleotides Erbkg3 5Ј-ATGAG-TATTCAGCCATGGCATTCTACAG and Erbkg4 5Ј-CAGGC-CTGGCCATCACTGAGACTG, which were constructed to encompass the entire coding region of rat ER␤ cDNA. To facilitate subsequent subcloning, an NcoI restriction enzyme recognition site was introduced over the start codon (bases Ϫ2 to ϩ4). The PCR product was visualised on a 1% agarose gel, revealing a single band of approximately 1450 bp, corresponding in size to the rat ER␤ open reading frame. The DNA band was excised and the DNA was purified using the QIAEX gel purification kit (QIAGEN, Hilden, Germany). The resulting DNA was phosphorylated with T4 polynucleotide kinase (Amersham, Solna, Sweden) and cloned into the Toverhang vector pTKS (37) . The insert of pTKS-mER␤ was sequenced by the dideoxy method (38) with T7 DNA-polymerase (Pharmacia).
Plasmid Constructs
For in vitro transcription/translation in RRL, pTKS-mER␤ was digested with NcoI and EcoRI, which yielded a fragment encompassing the entire coding sequence (cds), which was inserted Sp6-sense into NcoI/EcoRI-digested pSP72 (Promega, Madison, WI), thus generating pSP72-mER␤. pSP72-mER␤-TAG was made by replacement of nucleotides 1-273 of the mER␤ cds with oligonucleotides 5Ј-CATGGGCTACCCCTAC-GACGTGCCCGACTACGCCGTGAACA and 5Ј-CTAGTGT-TCACGGCGTAGTCGGGCACGTCGTAGGGGTAGCC, which encode the HA1 epitope recognized by the 12CA5 monoclonal antibody. The plasmid pSP72-hER␣ has been described elsewhere (36) . For transfections of mammalian cells the XhoI/BglIIfragment from pSP72-mER␤ was inserted into the pSG5 expression vector (Stratagene, La Jolla, CA) digested with EcoRI/ BglII; the XhoI-site of the mER␤-fragment and the EcoRI-site of pSG5 were filled in with Klenow fragment to allow blunt-ended ligation. The vector pSG5-hER␣ was made by excising hER␣ cDNA from pSP72-hER␣ with EcoRI and SacI and inserting it into pSG5 digested with EcoRI and BglII. To enable this ligation, the SacI site was filled in with T4 DNA-polymerase and BglII with Klenow fragment. The reporter construct 2xERE-TK-Luc was constructed by subcloning of a tandem ERE (39) with XhoI overhangs into the SalI site of the p19-TK-Luc reporter plasmid (40) . The Gal4-mER␣ and VP16-mER␣ two-hybrid constructs were made through PCR amplification of the plasmid MOR101 (containing the mouse ER␣ cDNA) (41) to introduce a KpnI site upstream of the start codon of the mER␣, with the use of oligonucleotides mER-ATG (5Ј-GCCAGGTACCATGGCCAT-GACC) and mER-EagI (5Ј-CCCAGGCTGTTGGCACT-GAAGGC). The 275-bp long PCR product was cut with KpnI and EagI, MOR101 was digested with EagI (nucleotide 460 in the mouse ER␣ cDNA) and BamHI 3Ј of the mER␣ cDNA), and both fragments were subcloned into the KpnI and BamHI sites of pCMX-Gal4 or pCMX-VP16 (42). VP16-ER␤ was made by in-frame insertion of the NcoI/EcoRI fragment of pSP72-mER␤ into the EcoRV/EcoRI sites of pCMX-VP16, and the NcoI site of mER␤ was filled in with Klenow fragment to enable the ligation. The Gal4-luciferase reporter construct used in the two-hybrid assay has been described elsewhere (43) . The pGST-mER␤ was generated by in-frame ligation of the NcoI/EcoRI fragment from pSP72-mER␤ into the corresponding sites of pGST (I. Pongratz and F. Delauney, unpublished data) creating a GSTmER␤ fusion that could be translated in the RRL system.
Cell Culture and Transient Transfections
Cells from the human fetal kidney cell line 293 were routinely cultured in a 1:1 mixture of Ham's Nutrient mixture F12 (F12, GIBCO BRL) and DMEM (GIBCO-BRL) supplemented with 7.5% FBS, 0.5% nonessential amino acids (NEA, GIBCO BRL) and 1% PEST (100 U penicillin/ml and 100 g streptomycin/ml). Cells were seeded in six-well plates 24 h before transfection. Transfections using the Lipofectin (GIBCO BRL) reagent were performed as described by the manufacturer in a serum-and antibiotic-free mixture of 1:1 of F12 and phenolred free DMEM with 0.75 g of the 2xERE-TK-Luc reporter and 0.1-0.4 g of pSG5-ER␣ or pSG5-ER␤ as indicated. The pSG5 vector was used to equalize plasmid concentrations, and 0.1 g of a placental alkaline phosphatase (AP) expression plasmid (44) was included to control for differences in transfection efficiences. Medium was changed to a phenol red-free mixture of F12 and DMEM containing 7.5% dextrancoated charcoal-treated FBS, 0.5% NEA, and 1% PEST after 24 h. Hormone or vehicle (0.1% ethanol) was added simultaneously. Cells were allowed to stand for 48 h with a renewed change of media and hormone after 24 h. Media were collected for assaying of AP activity. The cells were harvested in 10 mM Tris-HCl/10 mM EDTA/150 mM NaCl and centrifuged for 4 min at 4000 rpm, supernatant was removed, and cell pellets were lysed in Lysis Buffer 2 (Bio-Orbit, Turku, Finland). Luciferase activity was measured using the GenGlow system (Bio Orbit). The results are presented as the mean Ϯ SD of fold induction of three separate transfections performed in duplicate.
COS 7 cells were routinely maintained in DMEM (GIBCO BRL) supplemented with 5% FBS and 1% PEST. For transient transfections, cells were seeded in six-well plates 24 h prior to transfection. Transfections were carried out with Lipofectin reagent in phenol red-free DMEM without serum and antibiotics, using 0.5 g of the GAL4-luciferase reporter construct and 0.1 g of each of the two-hybrid expression plasmids as indicated in the legend to Fig. 5B . Expression vector concentrations were kept constant in all transfections by addition of the original pCMX-Gal4 or pCMX-VP16 plasmids, and 0.2 g of the AP expression vector was included in all transfections as an internal control for transfection efficiency. Cells were left in the Lipofectin-DNA mixture for 24 h after which the medium was changed to phenol red-free DMEM supplemented with 5% dextran-coated charcoaltreated FBS and 1% PEST. Hormone (1 M E 2 ) or vehicle (0.1% ethanol) was added. After 24 h cells were harvested as described previously, and luciferase activity was measured. All samples were normalized against the activity of the AP internal standard. Transfections were carried out in duplicate, and the results are presented as fold induction and represent the mean value Ϯ SD of three separate experiments.
In Vitro Translation, GST Pulldown, and DNA-Binding Assays
For the ERE-binding studies, 1 g pSP72-mER␤ or 1 g pSP72-hER␣ was transcribed/translated in the TNT-coupled RRL system (Promega) with Sp6 RNA polymerase, according to the manufacturer's instructions, in the presence of 100 nM 17␤-estradiol or vehicle (0.01% ethanol). Five microliters of the lysate were used in each DNA-binding reaction with a 32 P end-labeled wild type or double-mutated ERE as indicated in the legend to Fig. 2 . Protein-DNA complexes were separated on 5% polyacrylamide/0.25ϫ Tris-borate-EDTA gels at ϳ10 V/cm, followed by drying and autoradiography at Ϫ70 C.
In the homodimerization experiments, increasing amounts of pSP72-mER␤-TAG (0, 0.1, 0.2, 0.3, and 0.4 g) were translated in the RRL together with decreasing amounts of pSP72-mER␤ (0.4, 0.3, 0.2, 0.1, and 0 g). Five microliters of programmed lysate were used in each DNA-binding reaction with radiolabeled ERE.
For the heterodimerization studies, 1 g pSP72-hER␣ or pSP72-mER␤ was translated in RRL. In the experiment of Fig.  6A, 5, 4, 3, 2, 1 or 0 l of ER␣-containing lysate were mixed with 0, 1, 2, 3, 4, or 5 l of ER␤ lysate and incubated 15 min on ice before the DNA-binding reaction with radiolabeled ERE.
Translations were carried out in the same manner for the antibody-upshift experiments, and 4 l ER␣ or ER␤ lysate, respectively, or a mixture of 2 l of each was incubated for 15 min on ice. Thereafter, 1.5 l monoclonal ER␣ antibody 1D5 (Dako, Carpinteria, CA) or 12CA5 TAG antibody (BAbCOf) were added to the respective homodimers and 0.5, 1, 2, or 3 l of each antibody were added to the heterodimer reactions. The DNA-binding reaction was started immediately. The single-mutated ERE used in the band shift assay in Fig. 6D has been described previously (36) . Four microliters of ER␣ or ER␤ protein containing RRL or a mix of 2 l of each were used in the DNA-binding assay.
For the GST pulldown experiments, pSP72-hER␣ was translated in the presence of [ 35 S]methionine in RRL and pGST-mER␤ or the original pGST was translated in RRL in the absence of radiolabeled amino acids. Five microliters of ER␣-containing lysate were mixed with 5 l lysate containing GST-mER␤ or GST-protein. Samples were incubated for 15 min on ice before 50 l GST-Sepharose diluted in PBS were added to each sample followed by 30 min of incubation on ice. The Sepharose beads were washed four times in PBS/ 0.1% Triton X-100, and bound proteins were eluted by incubation in 2ϫ SDS-buffer for 5 min at 100 C. ER␣ lysate (ϭ20%) was loaded as input together with the eluted samples on a 10% SDS-PAGE and run at 150 V. The gel was immersed in 1 M salicylic acid for 20 min, dried, and autoradiographed at Ϫ70 C.
